Lexicon Pharmaceuticals LXRX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $67.09M+5.9% | $63.33M-19.5% | $78.66M+56.2% | $50.36M-19.9% | $62.89M-5.7% | ||
| $132.57M+114% | $61.9M-6.6% | $66.29M-43.6% | $117.64M-10.8% | $131.95M-23.0% | ||
| $11.78M+394% | $2.38M+2.1% | $2.33M+6.9% | $2.18M-95.4% | $47.45M+1,266% | ||
| $276K-1.8% | $281K+77.8% | $158K-6.0% | $168K-16.4% | $201K-13.0% | ||
| $186.03M+82.6% | $101.9M-16.8% | $122.53M-15.5% | $145.08M-41.0% | $245.81M-0.2% | ||
| $1.75M-5.9% | $1.86M-6.0% | $1.98M-7.1% | $2.13M-7.6% | $2.31M-7.1% | ||
| $44.54M0.0% | $44.54M0.0% | $44.54M0.0% | $44.54M0.0% | $44.54M0.0% | ||
| $268.82M+45.3% | $184.99M-10.2% | $205.93M-8.7% | $225.58M-24.2% | $297.67M-0.3% | ||
| $3M-2.8% | $3.08M-18.8% | $3.8M-35.6% | $5.9M-44.8% | $10.69M-27.8% | ||
| —— | —— | —— | —— | —— | ||
| $9.9M-52.6% | $20.87M-3.9% | $21.72M-37.7% | $34.84M-68.5% | $110.69M+145% | ||
| $49.68M+0.6% | $49.41M-12.6% | $56.51M+0.7% | $56.11M-4.3% | $58.64M-41.5% | ||
| $65.96M-14.8% | $77.45M-9.7% | $85.77M-10.8% | $96.14M-44.9% | $174.64M+14.5% | ||
| 450M0.0% | 450M0.0% | 450M0.0% | 450M0.0% | 450M+123,867% | ||
| -$2.02B-0.1% | -$2.02B-0.8% | -$2B-0.6% | -$1.99B+0.2% | -$1.99B-1.3% | ||
| $202.86M+88.6% | $107.54M-10.5% | $120.16M-7.2% | $129.44M+5.2% | $123.03M-15.7% | ||
| $268.82M+45.3% | $184.99M-10.2% | $205.93M-8.7% | $225.58M-24.2% | $297.67M-0.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Lexicon Pharmaceuticals's total assets?
- Lexicon Pharmaceuticals (LXRX) holds $268.8M in total assets, down 9.7% year over year.
- How much debt does Lexicon Pharmaceuticals have?
- Lexicon Pharmaceuticals carries $57.7M in total debt against $202.9M of shareholders' equity, a debt-to-equity ratio of 0.28.
- How much cash does Lexicon Pharmaceuticals have?
- Lexicon Pharmaceuticals holds $67.1M in cash and equivalents.
- Can Lexicon Pharmaceuticals cover its short-term obligations?
- Its current ratio is 18.79 — current assets exceed current liabilities.
- Where does Lexicon Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Lexicon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
